Nature Communications (Dec 2020)
In vivo diversification of target genomic sites using processive base deaminase fusions blocked by dCas9
Abstract
In vivo mutagenesis systems can often show restricted capabilities and deleterious off-site mutations. Here the authors fuse base deaminases to T7 RNA polymerase to mutate a target sequence and use dCas9 to define the boundaries of the diversified DNA.